Roundtable Discussion: Accelerating Regulatory Approval by Applying Lessons from Successful & Challenged Ophthalmic Programs
4:45 pm - Wednesday 20th January 2027
- Learn directly from developers who have navigated approvals, regulatory delays, and setbacks to identify the strategies that improve submission success and reduce risk
- Understand common reasons for complete response letters and how to proactively address these issues in your development plan
- Discuss emerging regulatory considerations for novel modalities including gene therapies, cell therapies, and extended-release implants where precedents are still being established